Cite
APA Citation
Remák, E., Hawkins, N., Jones, T., Otley, M., Twigger, R., & Prince, M. (n.d.). understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data. European journal of cancer, 156, S18–. http://access.bl.uk/ark:/81055/vdc_100144488908.0x000022